Recursion Pharmaceuticals Company
Founded in 2013 in Salt Lake City, Utah, Recursion is a clinical-stage AI-driven drug discovery company. It uses high-throughput imaging, machine learning, and massive biological datasets to map cellular biology and discover novel therapeutics. Its platform applies to oncology, rare disease, and aging pathways, with acquisitions including Cyclica and Valence to expand AI chemistry capabilities. (recursion.com)
Investors
%20.jpg)
Connections from
Headquarters:
41 S Rio Grande St, Salt Lake City, UT 84101, US
Employee Number:
500
Founded Date:
2013
Estimated Revenue:
$58.8M (FY2024)